Shame on you Merck

Merck continues it's stellar string of "achievements" by creating a fraudulent peer-review journal to publish data that casts a favorable light on Fosamax and other drugs. I'm not surprised at this course off action from Merck, a company that hasn't had a blockbuster drug in years. I am more furious at Elsevier, a respected academic journal publisher, that did NOT [...]

An Introduction of Sorts

There are neither beginnings nor endings to the turning of the Wheel of time. But it was a beginning. -- Robert Jordan I knew I wanted to bring notsocommoncents back to life when I found myself blogging about the disruptive trends in business and technology on my company's SharePoint. Somehow, I had finally become comfortable [...]